Evaluating a new treatment approach for atrial fibrillation using renal artery denervation.
A Trial to Evaluate Renal Artery Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation (ERADICATE-AF II)
['FUNDING_OTHER'] · UNIVERSITY OF ROCHESTER · NIH-10685356
This study is looking at whether combining a procedure called renal artery denervation with catheter ablation can help people with atrial fibrillation have better heart rhythm control and fewer episodes of AF.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ROCHESTER (nih funded) |
| Locations | 1 site (ROCHESTER, UNITED STATES) |
| Trial ID | NIH-10685356 on ClinicalTrials.gov |
What this research studies
This research investigates the effectiveness of combining renal artery denervation (RDN) with catheter ablation to treat atrial fibrillation (AF). The study aims to determine if reducing sympathetic nerve stimulation through RDN can enhance the success of pulmonary vein isolation, a common procedure for AF. Patients participating in this trial will undergo both RDN and catheter ablation, with their heart rhythms monitored over time to assess improvements. The research builds on previous findings that suggest this combination may significantly reduce the recurrence of AF.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with paroxysmal atrial fibrillation who are considering catheter ablation.
Not a fit: Patients with persistent atrial fibrillation or those who have not responded to previous ablation therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for patients with atrial fibrillation, potentially reducing the need for multiple procedures.
How similar studies have performed: Previous studies, including the ERADICATE-AF trial, have shown promising results with similar approaches, indicating a potential for success.
Where this research is happening
ROCHESTER, UNITED STATES
- UNIVERSITY OF ROCHESTER — ROCHESTER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STEINBERG, JONATHAN S. — UNIVERSITY OF ROCHESTER
- Study coordinator: STEINBERG, JONATHAN S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.